210 related articles for article (PubMed ID: 33021335)
1. Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
Schnappauf O; Sampaio Moura N; Aksentijevich I; Stoffels M; Ombrello AK; Hoffmann P; Barron K; Remmers EF; Hershfield M; Kelly SJ; ; Cuthbertson D; Carette S; Chung SA; Forbess L; Khalidi NA; Koening CL; Langford CA; McAlear CA; Monach PA; Moreland L; Pagnoux C; Seo P; Springer JM; Sreih AG; Warrington KJ; Ytterberg SR; Kastner DL; Grayson PC; Merkel PA;
Arthritis Rheumatol; 2021 Mar; 73(3):512-519. PubMed ID: 33021335
[TBL] [Abstract][Full Text] [Related]
2. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
3. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
[TBL] [Abstract][Full Text] [Related]
4. Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.
Ganhão S; Loureiro GB; Oliveira DR; Dos-Reis-Maia R; Aguiar F; Quental R; Moura C; Barreira JL; Rodrigues M; Brito I
Clin Rheumatol; 2020 Dec; 39(12):3853-3860. PubMed ID: 32535845
[TBL] [Abstract][Full Text] [Related]
5. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M
Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
Human A; Pagnoux C
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
[TBL] [Abstract][Full Text] [Related]
7. A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants.
Parlar K; Tahir Turanli E; Nuhoglu Kantarci E; Hacioglu A; Kirectepe Aydin A; Ayla AY; Voyvoda U; Ozdogan H; Ugurlu S
Mod Rheumatol Case Rep; 2023 Dec; 8(1):121-124. PubMed ID: 37542433
[TBL] [Abstract][Full Text] [Related]
8. Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart.
Huang Z; Li T; Nigrovic PA; Lee PY
Clin Immunol; 2020 Jun; 215():108411. PubMed ID: 32276138
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance.
Schnappauf O; Zhou Q; Moura NS; Ombrello AK; Michael DG; Deuitch N; Barron K; Stone DL; Hoffmann P; Hershfield M; Applegate C; Bjornsson HT; Beck DB; Witmer PD; Sobreira N; Wohler E; Chiorini JA; Center TAG; Dalgard CL; Center NIS; Kastner DL; Aksentijevich I
J Clin Immunol; 2020 Aug; 40(6):917-926. PubMed ID: 32638197
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.
Grim A; Veiga KR; Saad N
Rheum Dis Clin North Am; 2023 Nov; 49(4):773-787. PubMed ID: 37821195
[TBL] [Abstract][Full Text] [Related]
12. Importance of the determination of enzymatic activity in the diagnosis of deficiency of adenosine deaminase 2 (DADA2).
Abbasi A; Batllori M; Gil-Sáez FJ; Rodríguez-Pintó I; Antón López J; Iglesias Jímenez E
Med Clin (Barc); 2022 Sep; 159(6):283-286. PubMed ID: 35241284
[TBL] [Abstract][Full Text] [Related]
13. Early-onset stroke and vasculopathy associated with mutations in ADA2.
Zhou Q; Yang D; Ombrello AK; Zavialov AV; Toro C; Zavialov AV; Stone DL; Chae JJ; Rosenzweig SD; Bishop K; Barron KS; Kuehn HS; Hoffmann P; Negro A; Tsai WL; Cowen EW; Pei W; Milner JD; Silvin C; Heller T; Chin DT; Patronas NJ; Barber JS; Lee CC; Wood GM; Ling A; Kelly SJ; Kleiner DE; Mullikin JC; Ganson NJ; Kong HH; Hambleton S; Candotti F; Quezado MM; Calvo KR; Alao H; Barham BK; Jones A; Meschia JF; Worrall BB; Kasner SE; Rich SS; Goldbach-Mansky R; Abinun M; Chalom E; Gotte AC; Punaro M; Pascual V; Verbsky JW; Torgerson TR; Singer NG; Gershon TR; Ozen S; Karadag O; Fleisher TA; Remmers EF; Burgess SM; Moir SL; Gadina M; Sood R; Hershfield MS; Boehm M; Kastner DL; Aksentijevich I
N Engl J Med; 2014 Mar; 370(10):911-20. PubMed ID: 24552284
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of adenosine deaminase 2 (DADA2): Review.
Sharma V; Deo P; Sharma A
Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101844. PubMed ID: 37328410
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.
Nanthapisal S; Murphy C; Omoyinmi E; Hong Y; Standing A; Berg S; Ekelund M; Jolles S; Harper L; Youngstein T; Gilmour K; Klein NJ; Eleftheriou D; Brogan PA
Arthritis Rheumatol; 2016 Sep; 68(9):2314-22. PubMed ID: 27059682
[TBL] [Abstract][Full Text] [Related]
16. A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon.
Trivioli G; Gelain E; Angelotti ML; Ravaglia F; Allinovi M; Lodi L; Caroti L; Buccoliero A; Emmi G; Gattorno M; Romagnani P; Volpi S; Vaglio A
Am J Kidney Dis; 2022 Nov; 80(5):677-682. PubMed ID: 35817275
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
Hashem H; Kelly SJ; Ganson NJ; Hershfield MS
Curr Rheumatol Rep; 2017 Oct; 19(11):70. PubMed ID: 28983775
[TBL] [Abstract][Full Text] [Related]
18. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
Navon Elkan P; Pierce SB; Segel R; Walsh T; Barash J; Padeh S; Zlotogorski A; Berkun Y; Press JJ; Mukamel M; Voth I; Hashkes PJ; Harel L; Hoffer V; Ling E; Yalcinkaya F; Kasapcopur O; Lee MK; Klevit RE; Renbaum P; Weinberg-Shukron A; Sener EF; Schormair B; Zeligson S; Marek-Yagel D; Strom TM; Shohat M; Singer A; Rubinow A; Pras E; Winkelmann J; Tekin M; Anikster Y; King MC; Levy-Lahad E
N Engl J Med; 2014 Mar; 370(10):921-31. PubMed ID: 24552285
[TBL] [Abstract][Full Text] [Related]
19. Histiocytoid Sweet Syndrome Presenting in Two Sisters With Deficiency of Deaminase Type 2.
Hui Ong EL; Cooray S; Brogan P; Calonje E
Am J Dermatopathol; 2023 Jan; 45(1):47-50. PubMed ID: 36484606
[TBL] [Abstract][Full Text] [Related]
20. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
